External Advisory Board


Peter C. Adamson, MD*
Chief, Division of Clinical Pharmacology and Therapeutics
Director, Experimental Therapeutics in Oncology
Children’s Hospital of Philadelphia,
University of Pennsylvania School of Medicine


Hakim Djaballah, PhD
Chief Executive Officer,
Institut Pasteur Korea
Sampyeong-dong 696,
Bundang-gu, Seongnam-si,
Gyeonggi-do, Korea


Javed Khan, MD
Deputy Chief
Genetics Branch
Senior Investigator
Head, Oncogenomics Section
Center for Cancer Research
National Cancer Institute
Building 37, Room 2016B
Bethesda, MD 20892


Janet Shipley, PhD
Sarcoma Molecular Pathology Team,
Divisions of Molecular Pathology & Cancer Therapeutics
The Institute of Cancer Research
Sutton, Surrey, SM2 5NG,
United Kingdom


Jim Winkler, PhD
Chief Scientific Officer
Arvinas Inc,
5 Science Park,
New Haven, CT 06511


Beat W. Schäfer, PhD
University Children's Hospital
Divisions of Oncology
Steinwiesstrasse 75
8032 Zürich


Stephen W. Fesik, PhD
Professor of Biochemistry, Pharmacology, and Chemistry
Orrin H. Ingram II Chair in Cancer Research
Vanderbilt University School of Medicine
Department of Biochemistry
2200 Pierce Ave., 802/804 RRB Nashville, TN 37232-0146


Scott Armstong MD
Director, Leukemia Center
Department of Pediatrics
Memorial Sloan Kettering
275 York Avenue, New York, NY 10065